PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32594336-8 2020 Regarding biochemical factors, following colitis induction, TNF-alpha level and MPO activity were increased; nevertheless, dexamethasone (2 mg/kg) and bupropion (160 mg/kg) decreased the TNF-alpha and MPO activity. Bupropion 151-160 tumor necrosis factor Rattus norvegicus 60-69 32594336-8 2020 Regarding biochemical factors, following colitis induction, TNF-alpha level and MPO activity were increased; nevertheless, dexamethasone (2 mg/kg) and bupropion (160 mg/kg) decreased the TNF-alpha and MPO activity. Bupropion 151-160 tumor necrosis factor Rattus norvegicus 187-196 23953570-2 2013 Bupropion is an antidepressant known to inhibit TNF-alpha production. Bupropion 0-9 tumor necrosis factor Rattus norvegicus 48-57 30081056-8 2018 Bupropion showed a clear anti-oxidant/anti-inflammatory profile detected by the ELISA assay of malondialdehyde (MDA), reduced glutathione, and interleukin -6 (IL-6), and real-time gene expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and tumor necrosis factor-alpha (TNF-alpha). Bupropion 0-9 tumor necrosis factor Rattus norvegicus 254-281 30081056-8 2018 Bupropion showed a clear anti-oxidant/anti-inflammatory profile detected by the ELISA assay of malondialdehyde (MDA), reduced glutathione, and interleukin -6 (IL-6), and real-time gene expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and tumor necrosis factor-alpha (TNF-alpha). Bupropion 0-9 tumor necrosis factor Rattus norvegicus 283-292 23953570-9 2013 Bupropion in reduced intestinal I/R injury through immunomodulatory machanisms that involve inflammatory cytokines such as TNF-alpha. Bupropion 0-9 tumor necrosis factor Rattus norvegicus 123-132